DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,204,120 | -39.0% | 8,884 | -41.0% | 0.31% | -37.5% |
Q2 2023 | $3,613,920 | -20.0% | 15,058 | -16.0% | 0.50% | -31.4% |
Q1 2023 | $4,519,077 | +126.8% | 17,930 | +138.9% | 0.73% | +112.8% |
Q4 2022 | $1,992,243 | -99.0% | 7,506 | +867.3% | 0.34% | +971.9% |
Q3 2022 | $200,433,000 | +99124.3% | 776 | -2.8% | 0.03% | +18.5% |
Q2 2022 | $202,000 | -13.7% | 798 | 0.0% | 0.03% | 0.0% |
Q1 2022 | $234,000 | -18.8% | 798 | -8.9% | 0.03% | -3.6% |
Q4 2021 | $288,000 | +7.9% | 876 | 0.0% | 0.03% | +7.7% |
Q3 2021 | $267,000 | -1.1% | 876 | -12.9% | 0.03% | -7.1% |
Q2 2021 | $270,000 | -14.0% | 1,006 | -27.9% | 0.03% | -24.3% |
Q1 2021 | $314,000 | +9.8% | 1,396 | +8.6% | 0.04% | +2.8% |
Q4 2020 | $286,000 | -24.5% | 1,286 | -26.9% | 0.04% | -32.1% |
Q3 2020 | $379,000 | +42.5% | 1,760 | +1.4% | 0.05% | +60.6% |
Q4 2019 | $266,000 | -31.3% | 1,735 | -53.7% | 0.03% | -5.7% |
Q4 2018 | $387,000 | -4.9% | 3,750 | 0.0% | 0.04% | -35.2% |
Q3 2018 | $407,000 | +14.6% | 3,750 | +4.2% | 0.05% | +1.9% |
Q2 2018 | $355,000 | +0.9% | 3,600 | 0.0% | 0.05% | 0.0% |
Q1 2018 | $352,000 | -0.3% | 3,600 | -5.3% | 0.05% | -1.9% |
Q4 2017 | $353,000 | +8.3% | 3,800 | 0.0% | 0.05% | +3.8% |
Q3 2017 | $326,000 | +1.6% | 3,800 | 0.0% | 0.05% | -1.9% |
Q2 2017 | $321,000 | -1.2% | 3,800 | 0.0% | 0.05% | -1.9% |
Q1 2017 | $325,000 | +34.9% | 3,800 | +59.0% | 0.05% | -3.6% |
Q2 2016 | $241,000 | +6.2% | 2,390 | 0.0% | 0.06% | +16.7% |
Q1 2016 | $227,000 | -7.3% | 2,390 | -9.3% | 0.05% | -15.8% |
Q4 2015 | $245,000 | +2.1% | 2,635 | -6.6% | 0.06% | -14.9% |
Q3 2015 | $240,000 | +0.4% | 2,820 | 0.0% | 0.07% | +48.9% |
Q1 2015 | $239,000 | – | 2,820 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |